Recently, the "8th International Forum on Drug-Induced Liver Injury (DILI) and the 9th National Academic Conference on Drug-Induced Liver Injury, along with the launch of the '2024 Chinese Guidelines for Grassroots Diagnosis and Management of Drug-Induced Liver Injury,'" was successfully held in beautiful Xiamen. This year's conference focused on the management of liver injury caused by anti-tumor drugs, inviting numerous renowned experts and scholars from home and abroad for rich academic exchanges. Professor Yimin Mao from Renji Hospital, the conference chairman, gave a detailed and in-depth explanation on the conference highlights, international influence, guideline updates, and industry development in a interview with Hepatology Digest.

Under long-term and repeated stimulation from various causes, a normal liver can develop into cirrhosis. Histologically, cirrhosis is characterized by diffuse liver fibrosis accompanied by collapse of the lobular structure (including microvascular structures) and the formation of pseudolobules, leading to portal hypertension and even liver function decompensation. Professor Hong You's team at Beijing Friendship Hospital, Capital Medical University, was the first in the world to propose a new pathological standard for evaluating the reversal of hepatitis B-induced cirrhosis. This new standard, known internationally as the "Beijing Standard," not only increases the recognition rate of cirrhosis reversal but also changes the clinical practice of requiring two liver biopsies for evaluation. Recently, at the "25th National Academic Conference on Traditional Chinese Medicine for Hepatobiliary Diseases," Hepatology Digest conducted an exclusive interview with Professor Hong You to discuss the diagnosis of cirrhosis reversal and other related issues. Here are the highlights of the interview.